Skip to main content
Home
Search
About
Attendee Snapshot
Event Announcements
Frequently Asked Questions
Plan
Registration
Promote
NEW Innovation Stage
Become a Sponsor
Global Marketplace
Company Presentations
Start-Up Stadium
Academic Campus
Learn
Interactive Education
Partner
BIO One-on-One Partnering™
Catch Up From 2020
2020 Partnering Companies
2020 Sessions
2020 Speakers
2020 By the Numbers
Search General Info
Search Education
Search Partnering Companies
×
×
Search General Info
Search
×
Search Education
Session Title
Session Keywords
Speaker Name
Search
×
×
Search Partnering Companies
Company Name
City
State
Country/Region
Argentina
Australia
Austria
Belgium
Brazil
Canada
Chile
China
Colombia
Costa Rica
Croatia
Czech Republic
Denmark
Estonia
Finland
France
Germany
Greece
Hong Kong
Hungary
Iceland
India
Indonesia
Ireland
Israel
Italy
Japan
Lithuania
Luxembourg
Malaysia
Mauritius
Mexico
Netherlands
New Zealand
Norway
Poland
Portugal
Puerto Rico
Russia
Singapore
Slovenia
South Korea
Spain
Sweden
Switzerland
Taiwan
Thailand
Turkey
Ukraine
United Arab Emirates
United Kingdom
United States
Uruguay
Search
BIO Digital
Speakers & Presenters
Meet the experts speaking on our world-class education program.
June 10-11 & 14-18, 2021
Search
Event Menu
Event Menu
About
Attendee Snapshot
Event Announcements
Frequently Asked Questions
Plan
Registration
Promote
NEW Innovation Stage
Become a Sponsor
Global Marketplace
Company Presentations
Start-Up Stadium
Academic Campus
Learn
Interactive Education
Partner
BIO One-on-One Partnering™
Catch Up From 2020
2020 Partnering Companies
2020 Sessions
2020 Speakers
2020 By the Numbers
General Info
Education
Partnering Companies
×
Search General Info
Search
Search Education
Session Title
Session Keywords
Speaker Name
Search
×
Search Partnering Companies
Company Name
City
State
Country/Region
Argentina
Australia
Austria
Belgium
Brazil
Canada
Chile
China
Colombia
Costa Rica
Croatia
Czech Republic
Denmark
Estonia
Finland
France
Germany
Greece
Hong Kong
Hungary
Iceland
India
Indonesia
Ireland
Israel
Italy
Japan
Lithuania
Luxembourg
Malaysia
Mauritius
Mexico
Netherlands
New Zealand
Norway
Poland
Portugal
Puerto Rico
Russia
Singapore
Slovenia
South Korea
Spain
Sweden
Switzerland
Taiwan
Thailand
Turkey
Ukraine
United Arab Emirates
United Kingdom
United States
Uruguay
Search
2020 BIO Digital Thought Leaders
All Speakers
Search
Filter
Session Types & Networking
Focus Areas
Interests
Company Presentations
Reset
Apply Filter
×
By Count
|
Alphabetical
Company Presentations
(341)
On Demand Sessions
(303)
Interactive Sessions
(124)
Interactive Super Sessions
(41)
Interactive Special Programs
(29)
Start-Up Stadium
(27)
Global Innovation Hubs
(24)
Interactive Plenaries
(22)
On Demand Special Programs
(17)
Interactive Fireside Chat
(10)
BioProcess International Theater
(5)
Show All
×
By Count
|
Alphabetical
COVID-19
(93)
Business Development and Finance
(51)
Digital Health
(46)
Oncology
(38)
Orphan and Rare Diseases
(34)
Infectious Disease and Vaccines
(32)
Value‚ Patient Access and Reimbursement
(28)
Brain Health
(27)
Personalized Medicine and Diagnostics
(26)
Next Generation Biotherapeutics
(23)
Emerging Opportunities in Global Markets
(21)
Cell & Gene Therapies and Genome Editing
(21)
Patient Advocacy
(17)
Highly Prevalent Chronic Diseases
(15)
Intellectual Property
(13)
Translational Research
(9)
Workforce Development
(9)
Emerging Therapies
(5)
Emerging Techniques, Technologies and Strategies
(1)
Show All
×
By Count
|
Alphabetical
Therapeutics
(126)
Oncology
(99)
COVID-19
(90)
Personalized Medicine
(81)
Preclinical/Research
(81)
Biologics
(76)
Business Development
(76)
CNS/Neurological
(73)
Small Molecules
(70)
Immunology
(69)
Gene/Cell Therapy
(64)
Infectious Diseases
(61)
Diagnostics
(60)
Genomics
(60)
Neurological Disease
(57)
Drug Delivery
(55)
Digital Health
(52)
Medical Devices
(47)
Cell Biology
(44)
Inflammatory Disease
(43)
Screening
(42)
Biomanufacturing
(41)
Translational Research
(41)
Vaccines
(40)
Regulatory Innovation
(40)
Molecular Diagnostics
(39)
Bioinformatics
(39)
Regenerative Medicine
(38)
Metabolic Diseases
(37)
Genetic Disorders
(35)
Intellectual Property
(35)
Contract Research
(34)
Cardiovascular
(33)
Research Tools
(32)
Autoimmune Disease
(31)
Immune Disorder
(31)
Brain Health
(30)
Stem Cell Research
(29)
Gastroenterology
(28)
Musculoskeletal
(26)
Hematology
(25)
Contract Manufacturing
(25)
Proteomics
(25)
Ophthalmology
(25)
Tissue Engineering
(25)
Respiratory
(24)
Transplant Medicine
(22)
Degeneration
(21)
Endocrinology
(20)
Pain Management
(20)
Gene Editing
(20)
Mental Health
(20)
Biobased Products
(19)
Renal
(19)
Nanotechnology
(18)
Urology
(17)
Workforce Development
(17)
Functional Genetics
(17)
Biodefense
(16)
Regulatory Science
(15)
Opioids
(15)
Pulmonary
(15)
Pharmacogenomics
(14)
Psychiatric
(14)
Reproductive Medicine
(13)
Dermatology
(13)
Imaging
(12)
Genitourinary
(12)
Transgenics
(12)
Genetically-enhanced Microbes
(12)
Ocuylar
(11)
One Health
(11)
Prophylaxis
(11)
Diversity
(10)
Nutraceuticals
(10)
Chemicals
(9)
Gynecology and obstetrics
(9)
Plant-made Pharmaceuticals
(8)
Biocatalysis
(8)
Multiline Global Biopharma
(8)
Bio-Energy
(7)
Nutritional Disorder
(7)
Aquaculture
(7)
Animal-made Pharmaceuticals
(7)
Toxicity and Intoxication
(6)
Micro Arrays
(6)
Personal Care
(6)
Growth Disorder
(5)
Industrial Chemicals
(5)
Industrial Enzymes
(5)
Microfluidics
(5)
Food Additives
(4)
Show All
×
Company Type
Privately Funded Company
(230)
Publicly Traded Company
(80)
Advocacy/Non-Profit/Other
(29)
Show All
Main Therapeutic Focus
Oncology
(67)
CNS/Neurological
(34)
Other
(31)
Multiple Therapeutics
(30)
Platform for Therapeutics
(19)
Tools/Drug Development Support Tech
(17)
Gene/Cell Therapy
(15)
Contract Research Organization
(12)
Infectious Diseases
(11)
Digital Health
(11)
Orphan/Rare Diseases
(9)
Contract Manufacturing Organization
(9)
Regenerative Medicine
(8)
Metabolic Diseases
(8)
Ophthalmology
(7)
Diagnostics
(6)
Gastrointestinal
(5)
Inflammation
(5)
Medical Devices
(5)
Dermatology
(4)
Immunology
(4)
Multiline Global Biopharma
(4)
Non-Profit/Patient Advocacy Group
(4)
Cardiovascular
(4)
Pain Management
(3)
COVID-19
(2)
Industrial & Environmental
(2)
Reproductive/Sexual Health
(2)
Respiratory
(2)
Food & Agriculture
(1)
Renewable Chemicals
(1)
Show All
Development Phase of Primary Product
Pre-Clinical
(92)
Other/Not Applicable
(67)
Phase I
(33)
Phase II
(33)
Multiple Products in Market
(33)
Phase III
(28)
Discovery
(13)
NDA Preparation / In Review
(9)
Phase IV
(1)
Show All
×
Search Speakers
Speaker Name
Country/Region
Australia
Austria
Belgium
Canada
China
Costa Rica
Denmark
France
Germany
Hong Kong
Hungary
India
Israel
Italy
Japan
Korea, Republic of
Luxembourg
Netherlands
New Zealand
Norway
Poland
Spain
Sweden
Switzerland
Taiwan
United Kingdom
United States
Company
Search
All Speakers
Search
Filter
Filter by letter
Please Select ...
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
×
Filter Speakers
Session Types & Networking
Please Select ...
Company Presentations (341)
On Demand Sessions (303)
Interactive Sessions (124)
Interactive Super Sessions (41)
Interactive Special Programs (29)
Start-Up Stadium (27)
Global Innovation Hubs (24)
Interactive Plenaries (22)
On Demand Special Programs (17)
Interactive Fireside Chat (10)
BioProcess International Theater (5)
Focus Areas
Please Select ...
COVID-19 (93)
Business Development and Finance (51)
Digital Health (46)
Oncology (38)
Orphan and Rare Diseases (34)
Infectious Disease and Vaccines (32)
Value‚ Patient Access and Reimbursement (28)
Brain Health (27)
Personalized Medicine and Diagnostics (26)
Next Generation Biotherapeutics (23)
Emerging Opportunities in Global Markets (21)
Cell & Gene Therapies and Genome Editing (21)
Patient Advocacy (17)
Highly Prevalent Chronic Diseases (15)
Intellectual Property (13)
Translational Research (9)
Workforce Development (9)
Emerging Therapies (5)
Emerging Techniques, Technologies and Strategies (1)
Interests
Please Select ...
Therapeutics (126)
Oncology (99)
COVID-19 (90)
Personalized Medicine (81)
Preclinical/Research (81)
Biologics (76)
Business Development (76)
CNS/Neurological (73)
Small Molecules (70)
Immunology (69)
Gene/Cell Therapy (64)
Infectious Diseases (61)
Diagnostics (60)
Genomics (60)
Neurological Disease (57)
Drug Delivery (55)
Digital Health (52)
Medical Devices (47)
Cell Biology (44)
Inflammatory Disease (43)
Screening (42)
Biomanufacturing (41)
Translational Research (41)
Vaccines (40)
Regulatory Innovation (40)
Molecular Diagnostics (39)
Bioinformatics (39)
Regenerative Medicine (38)
Metabolic Diseases (37)
Genetic Disorders (35)
Intellectual Property (35)
Contract Research (34)
Cardiovascular (33)
Research Tools (32)
Autoimmune Disease (31)
Immune Disorder (31)
Brain Health (30)
Stem Cell Research (29)
Gastroenterology (28)
Musculoskeletal (26)
Hematology (25)
Contract Manufacturing (25)
Proteomics (25)
Ophthalmology (25)
Tissue Engineering (25)
Respiratory (24)
Transplant Medicine (22)
Degeneration (21)
Endocrinology (20)
Pain Management (20)
Gene Editing (20)
Mental Health (20)
Biobased Products (19)
Renal (19)
Nanotechnology (18)
Urology (17)
Workforce Development (17)
Functional Genetics (17)
Biodefense (16)
Regulatory Science (15)
Opioids (15)
Pulmonary (15)
Pharmacogenomics (14)
Psychiatric (14)
Reproductive Medicine (13)
Dermatology (13)
Imaging (12)
Genitourinary (12)
Transgenics (12)
Genetically-enhanced Microbes (12)
Ocuylar (11)
One Health (11)
Prophylaxis (11)
Diversity (10)
Nutraceuticals (10)
Chemicals (9)
Gynecology and obstetrics (9)
Plant-made Pharmaceuticals (8)
Biocatalysis (8)
Multiline Global Biopharma (8)
Bio-Energy (7)
Nutritional Disorder (7)
Aquaculture (7)
Animal-made Pharmaceuticals (7)
Toxicity and Intoxication (6)
Micro Arrays (6)
Personal Care (6)
Growth Disorder (5)
Industrial Chemicals (5)
Industrial Enzymes (5)
Microfluidics (5)
Food Additives (4)
Company Presentations
Please Select ...
Privately Funded Company (230)
Publicly Traded Company (80)
Advocacy/Non-Profit/Other (29)
Oncology (67)
CNS/Neurological (34)
Other (31)
Multiple Therapeutics (30)
Platform for Therapeutics (19)
Tools/Drug Development Support Tech (17)
Gene/Cell Therapy (15)
Contract Research Organization (12)
Infectious Diseases (11)
Digital Health (11)
Orphan/Rare Diseases (9)
Contract Manufacturing Organization (9)
Regenerative Medicine (8)
Metabolic Diseases (8)
Ophthalmology (7)
Diagnostics (6)
Gastrointestinal (5)
Inflammation (5)
Medical Devices (5)
Dermatology (4)
Immunology (4)
Multiline Global Biopharma (4)
Non-Profit/Patient Advocacy Group (4)
Cardiovascular (4)
Pain Management (3)
COVID-19 (2)
Industrial & Environmental (2)
Reproductive/Sexual Health (2)
Respiratory (2)
Food & Agriculture (1)
Renewable Chemicals (1)
Pre-Clinical (92)
Other/Not Applicable (67)
Phase I (33)
Phase II (33)
Multiple Products in Market (33)
Phase III (28)
Discovery (13)
NDA Preparation / In Review (9)
Phase IV (1)
Apply
Reset
×
×
Search Speakers
Speaker Name
Country/Region
Australia
Austria
Belgium
Canada
China
Costa Rica
Denmark
France
Germany
Hong Kong
Hungary
India
Israel
Italy
Japan
Korea, Republic of
Luxembourg
Netherlands
New Zealand
Norway
Poland
Spain
Sweden
Switzerland
Taiwan
United Kingdom
United States
Company
Search
Filter by letter
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Stephen M. Hahn, MD
COMMISSIONER OF FOOD AND DRUGS, U.S. FOOD AND DRUG ADMINISTRATION
Fireside Chat with FDA Commissioner Dr. Stephen M. Hahn
Christian Haas-Kwon
LIFE SCIENCE R&D ENABLEMENT LEAD, BENCHLING
Benchling
San Francisco, California, United States
Kyung soo Hahm
DIRECTOR, BIOLEADERS
BioLeaders
Yongin-si, Korea, Republic of
Todd Haim, PhD
CHIEF, OFFICE OF SMALL BUSINESS RESEARCH, NIH/NIA
Brave Innovations: Public and Private Solutions to Advance Alzheimer’s Therapeutics and Diagnostic in a Risk-Averse Climate
Bethesda, Maryland, United States
William Hait, MD, PhD
GLOBAL HEAD, JOHNSON & JOHNSON EXTERNAL INNOVATION, JOHNSON & JOHNSON
Nature Biotechnology and Scientific American WORLDVIEW: Whiplash! How COVID-19 Will Radically Change Biomedical R&D Across the Globe
New Brunswick, New Jersey, United States
Attila Hajdu, MBA, MS
VICE PRESIDENT, BUSINESS DEVELOPMENT, TRIPLE HAIR
Triple Hair
Vancouver, British Columbia, Canada
Jeff Haley
DEVELOPMENT, CELANESE
Celanese
Florence, Kentucky, United States
Sonia Hall, PhD
PRESIDENT & CHIEF EXECUTIVE OFFICER, BIOKANSAS
Bioscience Professional Toolkit - How to successfully transition to a post-academic career
Shawnee, Kansas, United States
Laurie Halloran
CHIEF EXECUTIVE OFFICER, HALLORAN CONSULTING GROUP
'N of Few' - Clinical Trial Design for Small Cohorts
Boston, Massachusetts, United States
Reza Halse, PhD
HEAD, PACIFIC BD&L HUB AND PRESIDENT, MRL VENTURES FUND, MERCK
Merck
South San Francisco, California, United States
Aldric Hama
DIRECTOR, HAMAMATSU PHARMA RESEARCH, INC.
Hamamatsu Pharma Research, Inc.
Hamamatsu, Japan
Margaret Hamburg, MD
FOREIGN SECRETARY, NATIONAL ACADEMIES OF SCIENCE
A Way Forward: Winning the War on COVID through Vaccines
Protecting Our Long-Term Commitment to Care in a Post-Pandemic World
Dong Wook Han
CTO, ORGANFACTORY
OrganFactory
Cheongju, Korea, Republic of
Buhm Han
CTO, GENEALOGY INC.
Genealogy Inc.
Seoul, Korea, Republic of
Grace Han McMahon, JD, MBA
HEAD OF TRANSACTIONS, BUSINESS DEVELOPMENT & LICENSING PACIFIC INNOVATION HUB, MERCK
GETTING IT 'JUST RIGHT': The Goldilocks Strategy for Effective and Efficient IP Due Diligence Processes
South San Francisco, California, United States
Matt Handel
CEO, EXPRESSCELLS
ExpressCells
Philadelphia, Pennsylvania, United States
Susie Harborth
CHIEF FINANCIAL OFFICER & ADMINISTRATIVE PARTNER, MISSION BIOCAPITAL
How an Innovation Ecosystem Enables Growth During Times of Crisis and Beyond
United States
David Harel
CO-FOUNDER AND CEO, CYTOREASON
CytoReason
Tel Aviv, Israel
Robert Hariri, MD, PhD
CEO, CELULARITY
Natural Killer (NK) Cells: Pushing the Next Wave of Immuno-oncology Therapies
Warren, New Jersey, United States
Dan Haro
EXTERNAL ENGAGEMENT MANAGER, CORPORATE DEVELOPMENT, BIOGEN
Biogen
Cambridge, Massachusetts, United States
Meghan Harpole
NURSE, COVID-19 PATIENT, NURSE
Understanding the Voices of Patients: Unique Perspectives on Healthcare
United States
Christine Harrison
VICE PRESIDENT, CORPORATE AFFAIRS, ORCHARD THERAPEUTICS
Patient Engagement in Gene and Cell Therapy: What is Different?
District Of Columbia, United States
Beverly Harrison
HEAD, PATIENT STRATEGIES & SOLUTIONS, JANSSEN
Activating the Value of RWD/RWE in a COVID-19 World
Titusville, New Jersey, United States
Alan Hartman
PARTNER, CENTERVIEW PARTNERS
How to Get Acquired: What Companies Look for When in Acquisition Mode
Paul Hastings
PRESIDENT AND CEO, NKARTA THERAPEUTICS
Understanding the Voices of Patients: Unique Perspectives on Healthcare
Diversity and Inclusion in Biotech’s Explosion: ERG and Non-Profit Perspectives
South San Francisco, California, United States
Richard Hatchett
CHIEF EXECUTIVE OFFICER , CEPI
A Way Forward: Winning the War on COVID through Vaccines
London , United Kingdom
Rachel Haurwitz, PhD
PRESIDENT AND CEO, CARIBOU BIOSCIENCES
True North: Maintaining your vision and letting scientific innovation be your guide
Berkeley, California, United States
Lou Hawthorne
CEO, NANOTICS, LLC
NaNotics, LLC
Mill Valley, California, United States
Daria Hazuda
VP, INFECTIOUS DISEASES DISCOVERY & CHIEF SCIENTIFIC OFFICER, MRL CAMBRIDGE EXPLORATORY CENTER, MERCK & CO
Shifting the Treatment Paradigm: New tools to tackle antimicrobial resistance
Cambridge, Massachusetts, United States
Mary Hecht-Kissell, MBA
DIRECTOR, BUSINESS DEVELOPMENT, NORTH CAROLINA BIOTECHNOLOGY CENTER
North Carolina – a global life science leader
Research Triangle Park, North Carolina, United States
Jonathan Heeney
CEO, DIOSYNVAX LTD.
The Quest for a Universal Influenza Vaccine: Within reach or beyond our grasp?
Brenda Hefti, JD, PhD
SENIOR VICE PRESIDENT, INTELLECTUAL PROPERTY AND LICENSING, EXELIXIS
GETTING TO YES: Negotiating IP Terms in Contracts
Alameda, California, United States
Karen Heichman, PhD
SENIOR PROGRAM OFFICER, DIAGNOSTIC DEVELOPMENT, INNOVATIVE TECHNOLOGY SOLUTIONS, GLOBAL HEALTH DIVISION, BILL & MELINDA GATES FOUNDATION
Nature Biotechnology and Scientific American WORLDVIEW: Whiplash! How COVID-19 Will Radically Change Biomedical R&D Across the Globe
Mo Heidaran
VICE PRESIDENT TECHNICAL, REGULATORY AND TECHNICAL CMC CONSULTING CELL, GENE THERAPY AND TISSUE ENGINEERING, PAREXEL INTERNATIONAL
Discover/Develop: But How Will you Manufacture Your Therapeutic?
United States
Abraham Heifets, PhD
CEO, CO-FOUNDER, ATOMWISE, INC.
Atomwise, Inc.
Organs-on-a-Chip and AI: Realizing Potential Efficiencies in Drug Discovery and Development
San Francisco, California, United States
Per Hellsund, MBA
CEO, CYBREXA THERAPEUTICS
Getting to the Tumor: Beyond the First Generation of Tumor Targeting Technologies
Cybrexa Therapeutics
New Haven, Connecticut, United States
Adam Hickey
DEPUTY ASSISTANT ATTORNEY GENERAL, NATIONAL SECURITY DIVISION, US DEPARTMENT OF JUSTICE
Examining Foreign-Source Threats to Biotechnology: A Conversation with the National Security Community
James J. Hickman, PhD
CHIEF SCIENTIST , HESPEROS, INC.
Disruptive Thinking: New Tools To Transform Addiction Treatment
Hesperos, Inc
Orlando, Florida, United States
Michael Higgins
MANAGING DIRECTOR, BIOPHARMACEUTICALS EQUITY RESEARCH, LADENBURG THALMANN & CO. INC.
Disruptive Thinking: What's Next for Pain
New York, New York, United States
Katherine High, MD
VISITING PROFESSOR; CO-FOUNDER AND FORMER PRESIDENT AND HEAD OF R&D, ROCKEFELLER UNIVERSITY; SPARK THERAPEUTICS
Realizing the Promise of Gene Therapies for Patients Around the World: A Year of Progress
Philadelphia, Pennsylvania, United States
Quita Highsmith, MBA
CHIEF DIVERSITY OFFICER, GENENTECH
Can Precision Medicine Work for Everyone? Tackling the Challenge of Healthcare Disparities
South San Francisco, California, United States
Seiji Hirasaki
CEO, ORICIRO GENOMICS
OriCiro Genomics
Tokyo, Japan
Helen Ho, PhD
VICE PRESIDENT, HEAD OF CORPORATE DEVELOPMENT, BLUEPRINT MEDICINES
Licensing Clinical-Stage Assets to Greater China
William Ho
CHIEF EXECUTIVE OFFICER, INCYSUS THERAPEUTICS, INC.
Incysus Therapeutics, Inc.
NEW YORK, New York, United States
Joshua Hoffman
CO-FOUNDER AND CEO, ZYMERGEN
The Bio Revolution: Innovations transforming economies, societies, and our lives
San Francisco, California, United States
Michele Holcomb, PhD
EXECUTIVE VICE PRESIDENT, STRATEGY AND CORPORATE DEVELOPMENT, CARDINAL HEALTH
Rare Disease Therapies are No Longer Rare: Can the US Healthcare Reimbursement System Handle Chronic Treatments for Orphan Diseases
Ohio, United States
Natalie Holles
PRESIDENT AND CHIEF EXECUTIVE OFFICER, AUDENTES, AN ASTELLAS COMPANY
Realizing the Promise of Gene Therapies for Patients Around the World: A Year of Progress
Andy Holt
VP BUSINESS DEVELOPMENT , ASKBIO
AskBio
RTP , North Carolina, United States
Axel Hoos
SENIOR VICE PRESIDENT AND THERAPEUTIC AREA HEAD ONCOLOGY, GLAXOSMITHKLINE
Future of IO Checkpoint Combinations
Collegeville, Pennsylvania, United States
W. Keith Hoots, MD
DIRECTOR, DIVISION OF BLOOD DISEASES AND RESOURCES, NATIONAL HEART, LUNG, AND BLOOD INSTITUTE- NATIONAL INSTITUTES OF HEALTH
The human biologic response to vascular injury: a complex interaction among inflammation (innate and adaptive), coagulation and acuity of the injurious stimulus
Zachary Hornby
CEO, PRESIDENT AND DIRECTOR, BOUNDLESS BIO INC.
Looking for the Next Targeted Oncology Blockbuster
La Jolla, California, United States
Ken Horne
PRESIDENT & COO, TEON THERAPEUTICS, INC.
Teon Therapeutics, Inc.
Redwood City, California, United States
Robert House
SENIOR VICE PRESIDENT, GOVERNMENT CONTRACTS, OLOGY BIOSERVICES, INC
The Need for Speed: Developing COVID-19 Vaccines and Therapeutics
Alachua, Florida, United States
Sonny Hsiao
CEO AND PRESIDENT, ACEPODIA BIOTECH, INC.
Acepodia Biotech, Inc.
Burlingame, California, United States
Dar-Jen Hsieh, PhD
CEO, ACRO BIOMEDICAL CO., LTD.
ACRO Biomedical Co., Ltd.
Kaohsiung City, Taiwan
Pearl Huang, PhD
PRESIDENT AND CEO, CYGNAL THERAPEUTICS
Getting a seat at the table: how can new small companies enter the oncology space?
Cambridge, Massachusetts, United States
Tom Hughes, PhD
CEO, NAVITOR PHARMACEUTICALS
Redefining What it Means to Get Old: New Breakthroughs in Aging Biology
Cambridge , Massachusetts, United States
Kevin Kyung-Hwa Huh
VICE CHAIRMAN, KPBMA(KOREA PHARMACEUTICAL AND BIO-PHARMA MANUFACTURERS ASSOCIATION)
KPBMA(Korea Pharmaceutical and Bio-Pharma Manufacturers Association)
Seoul, Korea, Republic of
Greg Hunt, MP
MINISTER, DEPARTMENT OF HEALTH, AUSTRALIA
International Plenary Session: How are Global Leaders Collaborating to Combat the Pandemic?
Stephen Hurst, JD
CO-FOUNDER, EXECUTIVE CHAIRMAN AND CO-CEO, MIND MEDICINE
Disruptive Thinking: New Tools To Transform Addiction Treatment
Toronto, Ontario, Canada
Patricia Hurter
CEO, LYNDRA THERAPEUTICS
Lyndra Therapeutics
Watertown , Massachusetts, United States
Mikael Hwang
BUSINESS DEVELOPMENT , GENEMEDICINE CO., LTD.
GeneMedicine Co., Ltd.
Seoul, Korea, Republic of
Albert Hwang, MD
MANAGING DIRECTOR, HEALTHCARE, INVESTMENT BANKING, MORGAN STANLEY
Realizing the Promise of Gene Therapies for Patients Around the World: A Year of Progress
Load More